-
1
-
-
0032490288
-
Powerful placebo: The dark side of the randomized controlled trial
-
Kaptchuk TJ. Powerful placebo: the dark side of the randomized controlled trial. Lancet 1998;351:1722-25.
-
(1998)
Lancet
, vol.351
, pp. 1722-1725
-
-
Kaptchuk, T.J.1
-
2
-
-
33344461287
-
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
-
Ciegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
-
(2006)
N Engl J Med
, vol.354
, pp. 795-808
-
-
Ciegg, D.O.1
Reda, D.J.2
Harris, C.L.3
Klein, M.A.4
O'Dell, J.R.5
Hooper, M.M.6
-
3
-
-
56049109217
-
The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials
-
Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1716-1723
-
-
Zhang, W.1
Robertson, J.2
Jones, A.C.3
Dieppe, P.A.4
Doherty, M.5
-
4
-
-
0342902205
-
Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment
-
HrobjartssonA, Gotze PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-602.
-
(2001)
N Engl J Med
, vol.344
, pp. 1594-1602
-
-
Hrobjartsson, A.1
Gotze, P.C.2
-
5
-
-
21444446932
-
The placebo effect is powerful: Estimating placebo effects in medicine and psychotherapy randomized clinical trials
-
Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo effect is powerful: estimating placebo effects in medicine and psychotherapy randomized clinical trials. J Clin Psychology 2005;61:835-54.
-
(2005)
J Clin Psychology
, vol.61
, pp. 835-854
-
-
Wampold, B.E.1
Minami, T.2
Tierney, S.C.3
Baskin, T.W.4
Bhati, K.S.5
-
6
-
-
0036242181
-
What are the main methodological problems in the estimation of placebo effects?
-
Hrobjartsson A. What are the main methodological problems in the estimation of placebo effects? J Clin Epidemiology 2002;55:430-5.
-
(2002)
J Clin Epidemiology
, vol.55
, pp. 430-435
-
-
Hrobjartsson, A.1
-
7
-
-
43249121870
-
Components of placebo effect: Randomized controlled trial in patients with irritable bowel syndrome
-
Published Online First: 3 April, doi:10.1136/bmj.39524.439618.25
-
Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomized controlled trial in patients with irritable bowel syndrome. BMJ. Published Online First: 3 April 2008. doi:10.1136/bmj.39524.439618.25
-
(2008)
BMJ
-
-
Kaptchuk, T.J.1
Kelley, J.M.2
Conboy, L.A.3
Davis, R.B.4
Kerr, C.E.5
Jacobson, E.E.6
-
8
-
-
40449099371
-
Commercial features of placebo and therapeutic efficacy
-
Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008;299:1016-7.
-
(2008)
JAMA
, vol.299
, pp. 1016-1017
-
-
Waber, R.L.1
Shiv, B.2
Carmon, Z.3
Ariely, D.4
-
9
-
-
0037051872
-
Placebo response in studies of major depression. Variable, substantial, and growing
-
Walsh BT, Seidmann SN, Sysko R, Gould M. Placebo response in studies of major depression. Variable, substantial, and growing. JAMA 2002;287:1840-7.
-
(2002)
JAMA
, vol.287
, pp. 1840-1847
-
-
Walsh, B.T.1
Seidmann, S.N.2
Sysko, R.3
Gould, M.4
-
10
-
-
0037292587
-
The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials
-
Irvin JE, Hendricks PS, Brandon TH. The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials. Nicotine Tob Res 2003;5:27-35.
-
(2003)
Nicotine Tob Res
, vol.5
, pp. 27-35
-
-
Irvin, J.E.1
Hendricks, P.S.2
Brandon, T.H.3
-
11
-
-
0036803108
-
A comparison of placebo effects in clinical analgesic trials versu studies of placebo analgesia
-
Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versu studies of placebo analgesia. Pain 2002;99:443-52.
-
(2002)
Pain
, vol.99
, pp. 443-452
-
-
Vase, L.1
Riley, J.L.2
Price, D.D.3
-
12
-
-
5644272620
-
Overt versus covert treatment for pain, anxiety and Parkinson's disease
-
Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety and Parkinson's disease. Lancet Neurol 2004;3:679-84.
-
(2004)
Lancet Neurol
, vol.3
, pp. 679-684
-
-
Colloca, L.1
Lopiano, L.2
Lanotte, M.3
Benedetti, F.4
-
14
-
-
43249117660
-
What is the placebo effect worth?
-
Spiegel D, Harrington A. What is the placebo effect worth? BMJ 2008;336:967-8.
-
(2008)
BMJ
, vol.336
, pp. 967-968
-
-
Spiegel, D.1
Harrington, A.2
|